Achyut Healthcare Limited (ACHYUT.BO)
INR 4.41
(0.0%)
INR 4.41
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 309.52 Million INR | 101.77% |
| 2022 | 153.4 Million INR | 54.31% |
| 2021 | 99.41 Million INR | 2009.31% |
| 2020 | 4.71 Million INR | 72.89% |
| 2019 | 2.72 Million INR | 14.88% |
| 2018 | 2.37 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 319.3 Million INR | 0.0% |
| 2023 Q1 | 151.3 Million INR | -1.37% |
| 2023 FY | 309.52 Million INR | 101.77% |
| 2023 Q3 | 309.52 Million INR | 104.56% |
| 2023 Q4 | 309.52 Million INR | 0.0% |
| 2023 Q2 | 151.3 Million INR | 0.0% |
| 2022 Q1 | 108.12 Million INR | 8.75% |
| 2022 FY | 153.4 Million INR | 54.31% |
| 2022 Q4 | 153.4 Million INR | 0.0% |
| 2022 Q3 | 153.4 Million INR | 41.88% |
| 2022 Q2 | 108.12 Million INR | 0.0% |
| 2021 Q1 | 58.86 Million INR | 0.0% |
| 2021 FY | 99.41 Million INR | 2009.31% |
| 2021 Q4 | 99.42 Million INR | 0.02% |
| 2021 Q3 | 99.41 Million INR | 68.87% |
| 2021 Q2 | 58.86 Million INR | 0.0% |
| 2020 FY | 4.71 Million INR | 72.89% |
| 2019 FY | 2.72 Million INR | 14.88% |
| 2018 FY | 2.37 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Ajanta Pharma Limited | 46.38 Billion INR | 99.333% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | 91.563% |
| Sigachi Industries Limited | 6.94 Billion INR | 95.541% |
| Bal Pharma Limited | 3.2 Billion INR | 90.339% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | 97.343% |
| Medico Remedies Limited | 961.95 Million INR | 67.824% |
| Lasa Supergenerics Limited | 1.5 Billion INR | 79.484% |
| Venus Remedies Limited | 6.26 Billion INR | 95.062% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 93.99% |
| Alpa Laboratories Limited | 1.82 Billion INR | 83.051% |
| Nectar Lifesciences Limited | 21.91 Billion INR | 98.587% |
| Shilpa Medicare Limited | 30.93 Billion INR | 98.999% |
| Aarti Drugs Limited | 24.32 Billion INR | 98.727% |
| Lupin Limited | 239.97 Billion INR | 99.871% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 99.931% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 99.894% |
| Windlas Biotech Limited | 6.26 Billion INR | 95.057% |
| Suven Life Sciences Limited | 2.84 Billion INR | 89.136% |
| Eris Lifesciences Limited | 70.48 Billion INR | 99.561% |
| Valiant Laboratories Limited | 3.42 Billion INR | 90.968% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 99.225% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | 98.683% |
| Ipca Laboratories Limited | 111.01 Billion INR | 99.721% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | 97.45% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.964% |
| Bajaj HealthCare Limited | 7.65 Billion INR | 95.955% |
| RPG Life Sciences Limited | 5.12 Billion INR | 93.965% |
| Mankind Pharma Limited | 119.63 Billion INR | 99.741% |
| Laurus Labs Limited | 83.87 Billion INR | 99.631% |
| Piramal Pharma Limited | 153.11 Billion INR | 99.798% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | 92.351% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 99.794% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 99.52% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 99.784% |
| Unichem Laboratories Limited | 31.69 Billion INR | 99.023% |
| Sequent Scientific Limited | 15.4 Billion INR | 97.991% |
| Novartis India Limited | 9.24 Billion INR | 96.654% |
| Wanbury Limited | 3.43 Billion INR | 90.989% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | 98.627% |
| Wockhardt Limited | 76.49 Billion INR | 99.595% |
| Themis Medicare Limited | 5.66 Billion INR | 94.535% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | 85.741% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 99.732% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 98.914% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 99.92% |
| Divi's Laboratories Limited | 154.7 Billion INR | 99.8% |
| NATCO Pharma Limited | 69.06 Billion INR | 99.552% |
| Gufic Biosciences Limited | 10.92 Billion INR | 97.167% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 98.621% |
| Ind-Swift Limited | 6.54 Billion INR | 95.271% |
| Procter & Gamble Health Limited | 7.94 Billion INR | 96.104% |
| FDC Limited | 24.68 Billion INR | 98.746% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | 82.628% |
| Granules India Limited | 55.2 Billion INR | 99.439% |
| Medicamen Biotech Limited | 2.94 Billion INR | 89.491% |
| Alkem Laboratories Limited | 155.74 Billion INR | 99.801% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | 97.129% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | 34.26% |
| Brooks Laboratories Limited | 904.45 Million INR | 65.778% |
| Megasoft Limited | 3.65 Billion INR | 91.541% |
| ZIM Laboratories Limited | 4.46 Billion INR | 93.073% |
| Strides Pharma Science Limited | 58.39 Billion INR | 99.47% |
| Neuland Laboratories Limited | 18.32 Billion INR | 98.311% |
| Morepen Laboratories Limited | 12.93 Billion INR | 97.607% |
| Hikal Limited | 24.87 Billion INR | 98.756% |
| Indoco Remedies Limited | 21.44 Billion INR | 98.557% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 98.801% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | 87.107% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | 90.717% |
| Hester Biosciences Limited | 6.62 Billion INR | 95.327% |